The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Open accessAbstract
The present review is an update of the research and development efforts regarding the use of molecular biomarkers in the lung cancer screening setting. The two main unmet clinical needs, namely, the refinement of risk in order to improve the selection of individuals undergoing screening and the characterization of undetermined nodules found during the CT-based screening process are the object of the biomarkers described in the present review. We first propose some principles to optimize lung cancer biomarker discovery projects. Then, we summarize the discovery and developmental status of currently promising molecular candidates such as autoantibodies, complement fragments, miRNAs, circulating tumor DNA, DNA methylation, blood protein profiling, or RNA airway or nasal signatures. We also mention other emerging biomarkers or new technologies to follow such as exhaled breath biomarkers, metabolomics, sputum cell imaging, genetic predisposition studies or the integration of NGS in circulating DNA. We also underline the importance of integrating different molecular technologies together with imaging, radiomics and artificial intelligence. We list a number of completed ongoing or planned trials to show clinical utility of molecular biomarkers. Finally we comment on the future research challenges in the field of biomarkers in the context of lung cancer screening and propose a design of a trial to test clinical utility of one or several biomarker candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Radiomics: extracting more information from medical images using advanced feature analysis
Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The TRACERx consortium, Abbosh, C., The PEACE consortium, Birkbak, N. J., Wilson, G. A., Jamal-Hanjani, M., Constantin, T., Salari, R., Le Quesne, J., Moore, D. A., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,874
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686 · cited 1×
“Much is gained from the careful selection of the molecular approach chosen and should be guided by the intended use, where the biomarker would find potential clinical utility.(26) All too often investigators focus on versatility, seeking biomarkers that address multiple clinical needs such as risk assessment, diagnosi…”
BackgroundSetio, A. A. A., Ciompi, F., Litjens, G., Gerke, P., Jacobs, C., van Riel, S. J., Wille, M. M. W., Naqibullah, M., Sanchez, C. I., & van Ginneken, B. (2016) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2016.2536809 · Cited by 1,258
Direct detection of early-stage cancers using circulating tumor DNA
Phallen, J., Sausen, M., Adleff, V., Leal, A., Hruban, C., White, J., Anagnostou, V., Fiksel, J., Cristiano, S., Papp, E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2415 · Cited by 1,119
Dna Hypomethylation In Cancer Cells
Ehrlich, M. (2009) · Epigenomics · doi:10.2217/epi.09.33 · Cited by 1,060
Selection Criteria for Lung-Cancer Screening
Tammemägi, M. C., Katki, H. A., Hocking, W. G., Church, T. R., Caporaso, N., Kvale, P. A., Chaturvedi, A. K., Silvestri, G. A., Riley, T. L., Commins, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211776 · Cited by 1,029
Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., Lindeman, N., Lockwood, C. M., Rai, A. J., Schilsky, R. L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.8671 · Cited by 959
Volatile Organic Compounds of Lung Cancer and Possible Biochemical Pathways
Hakim, M., Broza, Y. Y., Barash, O., Peled, N., Phillips, M., Amann, A., & Haick, H. (2012) · Chemical Reviews · doi:10.1021/cr300174a · Cited by 953 · cited 1×
“Chief among these concerns is the widespread adoption of NLST age (55-74) and tobacco exposure (Pack-Years≥30) inclusion criteria by screening guidelines.”
BackgroundSelf-citationEsteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Peng, G., Hakim, M., Broza, Y. Y., Billan, S., Abdah-Bortnyak, R., Kuten, A., Tisch, U., & Haick, H. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605810 · Cited by 775
Tuck, M. K., Chan, D. W., Chia, D., Godwin, A. K., Grizzle, W. E., Krueger, K. E., Rom, W., Sanda, M., Sorbara, L., Stass, S., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr800545q · Cited by 739
Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., Calabrò, E., Croce, C. M., Pastorino, U., & Sozzi, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100048108 · Cited by 722
Self-citationSpiroMeta Consortium, McKay, J. D., Hung, R. J., Han, Y., Zong, X., Carreras-Torres, R., Christiani, D. C., Caporaso, N. E., Johansson, M., Xiao, X., et al. (2017) · Nature Genetics · doi:10.1038/ng.3892 · Cited by 720
Self-citationMulti-scale Convolutional Neural Networks for Lung Nodule Classification
Shen, W., Zhou, M., Yang, F., Yang, C., & Tian, J. (2015) · Lecture Notes in Computer Science · doi:10.1007/978-3-319-19992-4_46 · Cited by 592
European position statement on lung cancer screening
Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30861-6 · Cited by 587
Self-citationAirway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer
Spira, A., Beane, J. E., Shah, V., Steiling, K., Liu, G., Schembri, F., Gilman, S., Dumas, Y.-M., Calner, P., Sebastiani, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1556 · Cited by 572
Self-citationNakhleh, M. K., Amal, H., Jeries, R., Broza, Y. Y., Aboud, M., Gharra, A., Ivgi, H., Khatib, S., Badarneh, S., Har-Shai, L., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b04930 · Cited by 510
Self-citationThe LLP risk model: an individual risk prediction model for lung cancer
Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., & Field, J. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604158 · Cited by 490
Self-citationSupervised Machine Learning for Population Genetics: A New Paradigm
Schrider, D. R., & Kern, A. D. (2018) · Trends in Genetics · doi:10.1016/j.tig.2017.12.005 · Cited by 453
Sozzi, G., Boeri, M., Rossi, M., Verri, C., Suatoni, P., Bravi, F., Roz, L., Conte, D., Grassi, M., Sverzellati, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.4357 · Cited by 436
Self-citationSomatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
Rios Velazquez, E., Parmar, C., Liu, Y., Coroller, T. P., Cruz, G., Stringfield, O., Ye, Z., Makrigiorgos, M., Fennessy, F., Mak, R. H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0122 · Cited by 391
Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection
Aravanis, A. M., Lee, M., & Klausner, R. D. (2017) · Cell · doi:10.1016/j.cell.2017.01.030 · Cited by 367
Defining the biological basis of radiomic phenotypes in lung cancer
Grossmann, P., Stringfield, O., El-Hachem, N., Bui, M. M., Rios Velazquez, E., Parmar, C., Leijenaar, R. T., Haibe-Kains, B., Lambin, P., Gillies, R. J., et al. (2017) · eLife · doi:10.7554/elife.23421 · Cited by 365
Lee, S. H., Sung, J. Y., Yong, D., Chun, J., Kim, S. Y., Song, J. H., Chung, K. S., Kim, E. Y., Jung, J. Y., Kang, Y. A., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.10.016 · Cited by 354
Bianchi, F., Nicassio, F., Marzi, M., Belloni, E., Dall'Olio, V., Bernard, L., Pelosi, G., Maisonneuve, P., Veronesi, G., & Di Fiore, P. P. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100154 · Cited by 351
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers
Amos, C. I., Dennis, J., Wang, Z., Byun, J., Schumacher, F. R., Gayther, S. A., Casey, G., Hunter, D. J., Sellers, T. A., Gruber, S. B., et al. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0106 · Cited by 348
Self-citationMazzone, P. J., Silvestri, G. A., Patel, S., Kanne, J. P., Kinsinger, L. S., Wiener, R. S., Soo Hoo, G., & Detterbeck, F. C. (2018) · Chest · doi:10.1016/j.chest.2018.01.016 · Cited by 348
Self-citationRadiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas
Liu, Y., Kim, J., Balagurunathan, Y., Li, Q., Garcia, A. L., Stringfield, O., Ye, Z., & Gillies, R. J. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.02.001 · Cited by 318
Tammemagi, C. M., Pinsky, P. F., Caporaso, N. E., Kvale, P. A., Hocking, W. G., Church, T. R., Riley, T. L., Commins, J., Oken, M. M., Berg, C. D., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr173 · Cited by 310
Field, J. K., Duffy, S. W., Baldwin, D. R., Brain, K. E., Devaraj, A., Eisen, T., Green, B. A., Holemans, J. A., Kavanagh, T., Kerr, K. M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20400 · Cited by 296
Self-citationten Haaf, K., Jeon, J., Tammemägi, M. C., Han, S. S., Kong, C. Y., Plevritis, S. K., Feuer, E. J., de Koning, H. J., Steyerberg, E. W., & Meza, R. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002277 · Cited by 284
miR-Test: A Blood Test for Lung Cancer Early Detection
Montani, F., Marzi, M. J., Dezi, F., Dama, E., Carletti, R. M., Bonizzi, G., Bertolotti, R., Bellomi, M., Rampinelli, C., Maisonneuve, P., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv063 · Cited by 278
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Hulbert, A., Jusue-Torres, I., Stark, A., Chen, C., Rodgers, K., Lee, B., Griffin, C., Yang, A., Huang, P., Wrangle, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1371 · Cited by 275
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
Silvestri, G. A., Vachani, A., Whitney, D., Elashoff, M., Porta Smith, K., Ferguson, J. S., Parsons, E., Mitra, N., Brody, J., Lenburg, M. E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504601 · Cited by 273
Self-citationJenkins, S., Yang, J. C.-H., Ramalingam, S. S., Yu, K., Patel, S., Weston, S., Hodge, R., Cantarini, M., Jänne, P. A., Mitsudomi, T., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.04.003 · Cited by 269
Yousaf-Khan, U., van der Aalst, C., de Jong, P. A., Heuvelmans, M., Scholten, E., Lammers, J.-W., van Ooijen, P., Nackaerts, K., Weenink, C., Groen, H., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208655 · Cited by 263
Clinical validation of an autoantibody test for lung cancer
Boyle, P., Chapman, C. J., Holdenrieder, S., Murray, A., Robertson, C., Wood, W. C., Maddison, P., Healey, G., Fairley, G. H., Barnes, A. C., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq361 · Cited by 240
Tammemagi, M. C., Schmidt, H., Martel, S., McWilliams, A., Goffin, J. R., Johnston, M. R., Nicholas, G., Tremblay, A., Bhatia, R., Liu, G., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30597-1 · Cited by 216
Jett, J. R., Peek, L. J., Fredericks, L., Jewell, W., Pingleton, W. W., & Robertson, J. F. R. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2013.10.008 · Cited by 195
Mathé, E. A., Patterson, A. D., Haznadar, M., Manna, S. K., Krausz, K. W., Bowman, E. D., Shields, P. G., Idle, J. R., Smith, P. B., Anami, K., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0109 · Cited by 195
Non-invasive Breath Analysis of Pulmonary Nodules
Peled, N., Hakim, M., Bunn, P. A., Miller, Y. E., Kennedy, T. C., Mattei, J., Mitchell, J. D., Hirsch, F. R., & Haick, H. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182637d5f · Cited by 194
Self-citationEarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
Chapman, C. J., Healey, G. F., Murray, A., Boyle, P., Robertson, C., Peek, L. J., Allen, J., Thorpe, A. J., Hamilton-Fairley, G., Parsy-Kowalska, C. B., et al. (2012) · Tumor Biology · doi:10.1007/s13277-012-0379-2 · Cited by 188
Weiss, G., Schlegel, A., Kottwitz, D., König, T., & Tetzner, R. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.123 · Cited by 188
Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
Molina, R., Marrades, R. M., Augé, J. M., Escudero, J. M., Viñolas, N., Reguart, N., Ramirez, J., Filella, X., Molins, L., & Agustí, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0603oc · Cited by 186
Ajona, D., Pajares, M. J., Corrales, L., Perez-Gracia, J. L., Agorreta, J., Lozano, M. D., Torre, W., Massion, P. P., de-Torres, J. P., Jantus-Lewintre, E., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt205 · Cited by 176
Self-citationOoki, A., Maleki, Z., Tsay, J.-C. J., Goparaju, C., Brait, M., Turaga, N., Nam, H.-S., Rom, W. N., Pass, H. I., Sidransky, D., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1222 · Cited by 175
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins
Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer, Guida, F., Sun, N., Bantis, L. E., Muller, D. C., Li, P., Taguchi, A., Dhillon, D., Kundnani, D. L., Patel, N. J., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2078 · Cited by 169
Silvestri, G. A., Tanner, N. T., Kearney, P., Vachani, A., Massion, P. P., Porter, A., Springmeyer, S. C., Fang, K. C., Midthun, D., Mazzone, P. J., et al. (2018) · Chest · doi:10.1016/j.chest.2018.02.012 · Cited by 165
Self-citationShowe, M. K., Vachani, A., Kossenkov, A. V., Yousef, M., Nichols, C., Nikonova, E. V., Chang, C., Kucharczuk, J. C., Tran, B. G., Wakeam, E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1378 · Cited by 161
de-Torres, J. P., Wilson, D. O., Sánchez-Salcedo, P., Weissfeld, J. L., Bertó, J., Campo, A., Alcaide, A. B., García‐Granero, M., Celli, B. R., & Zulueta, J. J. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1210oc · Cited by 158
Self-citationPinsky, P. F., & Berg, C. D. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012010 · Cited by 156
Doseeva, V., Colpitts, T. L., Gao, G., Woodcock, J. B., & Knezevic, V. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0419-y · Cited by 154
Mazzone, P. J., Sears, C. R., Arenberg, D. A., Gaga, M., Gould, M. K., Massion, P. P., Nair, V. S., Powell, C. A., Silvestri, G. A., Vachani, A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201708-1678st · Cited by 154
Self-citationWang, J., Liu, Q., Yuan, S., Xie, W., Liu, Y., Xiang, Y., Wu, N., Wu, L., Ma, X., Cai, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07737-0 · Cited by 144
Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer
Agmon, I. N., Abud-Hawa, M., Liran, O., Gai-Mor, N., Ilouze, M., Onn, A., Bar, J., Shlomi, D., Haick, H., & Peled, N. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.02.017 · Cited by 138
Self-citationCirculating tumor DNA detection in lung cancer patients before and after surgery
Guo, N., Lou, F., Ma, Y., Li, J., Yang, B., Chen, W., Ye, H., Zhang, J.-B., Zhao, M.-Y., Wu, W., et al. (2016) · Scientific Reports · doi:10.1038/srep33519 · Cited by 132
Volatile fingerprints of cancer specific genetic mutations
Peled, N., Barash, O., Tisch, U., Ionescu, R., Broza, Y. Y., Ilouze, M., Mattei, J., Bunn, P. A., Hirsch, F. R., & Haick, H. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.01.008 · Cited by 124
Self-citationMaisonneuve, P., Bagnardi, V., Bellomi, M., Spaggiari, L., Pelosi, G., Rampinelli, C., Bertolotti, R., Rotmensz, N., Field, J. K., DeCensi, A., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0026 · Cited by 119
Self-citationSputum microRNA Biomarkers for Identifying Lung Cancer in Indeterminate Solitary Pulmonary Nodules
Xing, L., Su, J., Guarnera, M. A., Zhang, H., Cai, L., Zhou, R., Stass, S. A., & Jiang, F. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1873 · Cited by 112
Zhang, C., Yu, W., Wang, L., Zhao, M., Guo, Q., Lv, S., Hu, X., & Lou, J. (2017) · Journal of Cancer · doi:10.7150/jca.21368 · Cited by 111
Sullivan, F., Farmer, E. C. W., Mair, F. S., Treweek, S. P., Kendrick, D., Jackson, C., Robertson, C., Briggs, A. H., McCowan, C., Bedford, L. E., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3175-y · Cited by 110
Puchades‐Carrasco, L., Lewintre, E. J., Pérez-Rambla, C., Garcia‐García, F., Lucas-Domínguez, R., Fariñas, S. C., Blasco, A., Dopazo, J., Camps, C., & Pineda‐Lucena, A. (2016) · Oncotarget · doi:10.18632/oncotarget.7354 · Cited by 106
Wikoff, W. R., Hanash, S., DeFelice, B. C., Miyamoto, S., Barnett, M. J., Zhao, Y., Goodman, G. E., Feng, Z., Gandara, D. R., Fiehn, O., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.7779 · Cited by 105
Development and clinical application of radiomics in lung cancer
Chen, B., Zhang, R., Gan, Y., Yang, L., & Li, W. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0885-x · Cited by 105
Wielscher, M., Vierlinger, K., Kegler, U., Ziesche, R., Gsur, A., & Weinhäusel, A. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.025 · Cited by 103
Improving Selection Criteria for Lung Cancer Screening. The Potential Role of Emphysema
Sánchez-Salcedo, P., Wilson, D. O., de-Torres, J. P., Weissfeld, J. L., Bertó, J., Campo, A., Alcaide, A. B., Pueyo, J. C., Bastarrika, G., Seijo, L. M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1848oc · Cited by 102
Self-citationMieth, B., Kloft, M., Rodríguez, J. A., Sonnenburg, S., Vobruba, R., Morcillo-Suárez, C., Farré, X., Marigorta, U. M., Fehr, E., Dickhaus, T., et al. (2016) · Scientific Reports · doi:10.1038/srep36671 · Cited by 101
Massion, P. P., Healey, G. F., Peek, L. J., Fredericks, L., Sewell, H. F., Murray, A., & Robertson, J. F. R. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.143 · Cited by 100
Self-citationJi, X., Bossé, Y., Landi, M. T., Gui, J., Xiao, X., Qian, D. C., Joubert, P., Lamontagne, M., Li, Y., Gorlov, I. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05074-y · Cited by 88
Self-citationLeprieur, E. G., Herbretau, G., Duménil, C., Julié, C., Giraud, V., Labrune, S., Dumoulin, J., Tisserand, J. C., Emile, J., Blons, H., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1424675 · Cited by 86
Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review
Li, Y., Li, K., & Zhang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22404 · Cited by 81
Sestini, S., Boeri, M., Marchianò, A. V., Pelosi, G., Galeone, C., Verri, C., Suatoni, P., Sverzellati, N., Vecchia, C. L., Sozzi, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5210 · Cited by 80
Self-citationScreening High-Risk Populations for Lung Cancer: Guideline Recommendations
Roberts, H. C., Walker‐Dilks, C., Sivjee, K., Ung, Y., Yasufuku, K., Hey, A., & Lewis, N. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829fd3d5 · Cited by 78
The metabolomic detection of lung cancer biomarkers in sputum
Cameron, S. J. S., Lewis, K. E., Beckmann, M., Allison, G. G., Ghosal, R., Lewis, P. D., & Mur, L. A. J. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.02.006 · Cited by 78
Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection
Perez-Rogers, J. F., Gerrein, J., Anderlind, C., Liu, G., Zhang, S., Alekseyev, Y. O., Smith, K. P., Whitney, D. H., Johnson, W. E., Elashoff, D. A., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw327 · Cited by 72
Self-citationWen, C.-P., Zhang, F., Liang, D., Wen, C., Gu, J. H., Skinner, H. D., Chow, W., Ye, Y., Pu, X., Hildebrandt, M. A. T., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0748 · Cited by 65
Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study
Haznadar, M., Cai, Q., Krausz, K. W., Bowman, E. D., Margono, E., Noro, R., Thompson, M. D., Mathé, E. A., Munro, H. M., Steinwandel, M. D., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1191 · Cited by 59
Tanner, N. T., Dai, L., Bade, B. C., Gebregziabher, M., & Silvestri, G. A. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0914oc · Cited by 59
Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules
Pecot, C. V., Li, M., Zhang, X. J., Rajanbabu, R., Calitri, C. E., Bungum, A. O., Jett, J. R., Putnam, J. B., Callaway‐Lane, C., Deppen, S., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0932 · Cited by 57
Self-citationLin, Y., Leng, Q., Jiang, Z., Guarnera, M. A., Zhou, Y., Chen, X., Wang, H., Zhou, W., Cai, L., Fang, H.-B., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30822 · Cited by 57
Rodriguez, H., Težak, Ž., Mesri, M., Carr, S. A., Liebler, D. C., Fisher, S. J., Tempst, P., Hiltke, T., Kessler, L. G., Kinsinger, C. R., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.136416 · Cited by 56
Fahrmann, J. F., Grapov, D., DeFelice, B. C., Taylor, S. L., Kim, K., Kelly, K. L., Wikoff, W. R., Pass, H. I., Rom, W. N., Fiehn, O., et al. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160602 · Cited by 54
The Airway Transcriptome as a Biomarker for Early Lung Cancer Detection
Billatos, E. S., Vick, J. L., Lenburg, M. E., & Spira, A. E. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3187 · Cited by 54
Self-citationPeralbo‐Molina, Á., Calderón-Santiago, M., Priego‐Capote, F., Gámez, B. J., & de Castro, M. D. L. (2016) · Journal of Breath Research · doi:10.1088/1752-7155/10/2/026002 · Cited by 53
Tensions in ethics and policy created by National Precision Medicine Programs
Minari, J., Brothers, K. B., & Morrison, M. C. (2018) · Human Genomics · doi:10.1186/s40246-018-0151-9 · Cited by 45
Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging
Boeri, M., Sestini, S., Fortunato, O., Verri, C., Suatoni, P., Pastorino, U., & Sozzi, G. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1041377 · Cited by 42
Self-citationEdelsberg, J., Weycker, D. A., Atwood, M., Hamilton-Fairley, G., & Jett, J. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197826 · Cited by 42
Roś-Mazurczyk, M., Wojakowska, A., Marczak, Ł., Polański, K., Pietrowska, M., Polańska, J., Dziadziuszko, R., Jassem, J., Rzyman, W., & Widłak, P. (2017) · Acta Biochimica Polonica · doi:10.18388/abp.2017_1517 · Cited by 40
Martínez‐Terroba, E., Behrens, C., de Miguel, F. J., Agorreta, J., Monsó, E., Millares, L., Sainz, C., Mesa, M., Perez‐Gracia, J. L., Lozano, M. D., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5096 · Cited by 39
Self-citationvan Riel, S. J., Ciompi, F., Wille, M. M. W., Dirksen, A., Lam, S. C., Scholten, E. T., Rossi, S. E., Sverzellati, N., Naqibullah, M., Wittenberg, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185032 · Cited by 37
Progress in the Development of Volatile Exhaled Breath Signatures of Lung Cancer
Mazzone, P. J., Wang, X., Lim, S. H., Jett, J. R., Choi, H., Zhang, Q., Beukemann, M., Seeley, M., Martino, R., & Rhodes, P. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201411-540oc · Cited by 36
Self-citationSmyth, R., Toomey, S., Sartori, A., O'Hanrahan, E., Cuffe, S. D., Breathnach, O. S., Morgan, R. K., & Hennessy, B. T. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.04.033 · Cited by 34
Lee, J., Li, B., Cui, Y., Sun, X., Wu, J., Zhu, H., Yu, J., Gensheimer, M. F., Loo, B. W., Diehn, M., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.006 · Cited by 28
Lococo, F., Principe, R., Cesario, A., Apolone, G., Carleo, F., Ialongo, P., Veronesi, G., & Cardillo, G. (2014) · Lung · doi:10.1007/s00408-014-9661-y · Cited by 27
Oxnard, G. R., Maddala, T., Hubbell, E. A., Aravanis, A. M., Zhang, N., Venn, O., Valouev, A., Shen, L., Patel, S. A., Jamshidi, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.18_suppl.lba8501 · Cited by 25
The Pursuit of Noninvasive Diagnosis of Lung Cancer
Atwater, T., Cook, C., & Massion, P. P. (2016) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0036-1592314 · Cited by 23
Self-citationMa, J., Guarnera, M. A., Zhou, W., Fang, H., & Jiang, F. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.11.001 · Cited by 23
Caiola, E., Brunelli, L., Marabese, M., Broggini, M., Lupi, M., & Pastorelli, R. (2016) · Oncotarget · doi:10.18632/oncotarget.9849 · Cited by 22
Fusco, J. P., Pita, G., Pajares, M. J., Andueza, M. P., Patiño‐García, A., de-Torres, J. P., Gúrpide, A., Zulueta, J. J., Alonso, R., Álvarez, N., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1500 · Cited by 22
Self-citationPrognostic and predictive biomarkers post curative intent therapy
Feldman, R. A., & Kim, E. S. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.07.34 · Cited by 21
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening–Detected Lung Cancers
Verri, C., Borzi, C., Holscher, T. D., Dugo, M., Devecchi, A., Drake, K., Sestini, S., Suatoni, P., Romeo, E., Sozzi, G., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.03.001 · Cited by 18
Self-citationIn-Silico Prediction of Key Metabolic Differences between Two Non-Small Cell Lung Cancer Subtypes
Rezola, A., Pey, J., Rubio, Á., & Planes, F. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103998 · Cited by 16
Screening for Lung Cancer: What Comes Next?
Peled, N., & Ilouze, M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.1713 · Cited by 13
Self-citationNichols, J. A., Grob, P. R., de Lusignan, S., Kite, W., & Williams, P. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-77 · Cited by 8
Author response: Defining the biological basis of radiomic phenotypes in lung cancer
Großmann, P., Stringfield, O., El-Hachem, N., Bui, M. M., Velazquez, E. R., Parmar, C., Leijenaar, R. T. H., Haibe‐Kains, B., Lambin, P., Gillies, R. J., et al. (2017) · eLife · doi:10.7554/elife.23421.027 · Cited by 6
Cited by
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Pastorino, U., Silva, M., Sestini, S., Sabia, F., Boeri, M., Cantarutti, A., Sverzellati, N., Sozzi, G., Corrao, G., & Marchianò, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz117 · Cited by 523
Self-citationLung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives
Oudkerk, M., Liu, S., Heuvelmans, M. A., Walter, J. E., & Field, J. K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00432-6 · Cited by 519
Self-citationDetection and characterization of lung cancer using cell-free DNA fragmentomes
Mathios, D., Johansen, J. S., Cristiano, S., Medina, J. E., Phallen, J., Larsen, K. R., Bruhm, D. C., Niknafs, N., Ferreira, L., Adleff, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24994-w · Cited by 472
Adams, S. J., Stone, E., Baldwin, D. R., Vliegenthart, R., Lee, P., & Fintelmann, F. J. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01694-4 · Cited by 467
Metadata
- Authors
- Seijo, L. M., Peled, N., Ajona, D., Boeri, M., Field, J. K., Sozzi, G., Pio, R., Zulueta, J. J., Spira, A., Massion, P. P., Mazzone, P. J., & Montuenga, L. M.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 14
- Issue
- 3
- Pages
- 343-357
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2903411538
- Cited by
- 539
- References
- 112
- FWCI
- 23.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.